Assignee
SHANGHAI CELLIVER BIOTECHNOLOGY CO LTD
CN·2 granted patents·4 pending applications·0 citations·filing 2019–2025
Top patents by PatentIndex Score
6 records- 0158US2025290046A1Method for constructing hepatic progenitor cell-like cell bank, cell lines prepared therefrom and application thereofSHANGHAI CELLIVER BIOTECHNOLOGY CO LTD·Filed 2025·Application pending·0 cites
- 0252US2023414676A1Liver disease regulatory formulation and use thereofSHANGHAI CELLIVER BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0344US12351828B2Method for constructing hepatic progenitor cell-like cell bank, cell lines prepared therefrom and application thereofSHANGHAI CELLIVER BIOTECHNOLOGY CO LTD·Filed 2020·Granted Jul 8, 2025·0 cites·3 claims
- 0441US2022389387A1Methods for amplifying and differentiating pancreatic cells, and application thereofSHANGHAI CELLIVER BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 0531US2022275339A1Hepatic precursor-like cell line, construction methods, and applications in the field of the bioartificial liversSHANGHAI CELLIVER BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 0629US12102743B2Bioreactor and biological reaction systemSHANGHAI CELLIVER BIOTECHNOLOGY CO LTD·Filed 2019·Granted Oct 1, 2024·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI CELLIVER BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →